| Claymont Family Dentistry | |
|
3009 Philadelphia Pike Claymont DE 19703-2508 | |
| (302) 793-0100 | |
| Not Available |
| Full Name | Claymont Family Dentistry |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 3009 Philadelphia Pike, Claymont, Delaware |
| Authorized Official Name and Position | Alan Son Nguyen (DENTIST) |
| Authorized Official Contact | 3027930100 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Claymont Family Dentistry 3009 Philadelphia Pike Claymont DE 19703-2508 Ph: (302) 793-0100 | Claymont Family Dentistry 3009 Philadelphia Pike Claymont DE 19703-2508 Ph: (302) 793-0100 |
| NPI Number | 1649540428 |
|---|---|
| Provider Enumeration Date | 01/10/2012 |
| Last Update Date | 01/10/2012 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649540428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
A Phase III, NRG Oncology clinical trial that compared radiosurgery or stereotactic body radiotherapy to the conventional radiotherapy for patients with spinal metastases indicated that there was no statistically significant difference between the treatments for pain response, adverse events, FACT-G, BPI, and EQ-5D scores.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
Researchers in the United States have found that individuals who develop more severe disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mount a larger antibody and memory B cell response during both acute infection and convalescence.
Researchers at the University of the Basque Country (UPV/EHU) and the Achucarro neurosciences centre have discovered a new therapy for the fragile X chromosome syndrome. This new therapy proposes the modulation of the cerebral endocannabinoid system in order to ameliorate the symptoms of the disease.
› Verified 9 days ago